Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications

被引:3
|
作者
Wu, Zhili [1 ,2 ]
Zhu, Yanru [1 ,2 ]
Liu, Wenchao [3 ]
Balasubramanian, Balamuralikrishnan [4 ]
Xu, Xiao [5 ]
Yao, Junhu [1 ,2 ]
Lei, Xinjian [1 ,2 ]
机构
[1] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China
[2] Northwest A&F Univ, Key Lab Livestock Biol, Yangling 712100, Peoples R China
[3] Guangzhou Ocean Univ, Coll Coastal Agr Sci, Zhanjiang 524088, Peoples R China
[4] Sejong Univ, Dept Food Sci & Biotechnol, Coll Life Sci, Seoul 05006, South Korea
[5] Wuhan Polytech Univ, Sch Anim Sci & Nutr Engn, Wuhan 430023, Peoples R China
基金
中国国家自然科学基金;
关键词
ferroptosis; natural active compounds; liver disease; therapeutic implications; IRON HOMEOSTASIS; CELL-DEATH; IN-VIVO; ACTIVATION; MECHANISMS; FIBROSIS; CANCER; ANTIOXIDANT; PROTECTS; PATHWAY;
D O I
10.3390/antiox13030352
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ferroptosis is an emerging type of regulated cell death usually accompanied by the accumulation of ferrous ions (Fe2+) and lipid peroxides. As the metabolic hub of the body, the liver is crucial for iron storage and lipid metabolism. The liver seems to be closely related to ferroptosis through iron and lipid metabolism. Liver disease greatly threatens host health, and exploring effective interventions is essential. Mounting studies have demonstrated that ferroptosis is one of the possible pathogenic mechanisms involved in liver disease. Targeting ferroptosis may provide a promising opportunity for treating liver disease. However, drugs targeting ferroptosis are extremely limited. Therefore, it is an urgent need to develop new and safe ferroptosis regulators. Natural active compounds (NAC), especially those derived from traditional Chinese medicine, have recently shown great therapeutic potential in liver disease via modulating ferroptosis-related genes or pathways. Here, we outline the molecular mechanism of ferroptosis and systematically summarize the regulatory function of NAC on ferroptosis in liver disease. Finally, we discuss the application prospects and potential problems concerning NAC as ferroptosis regulators for managing liver disease.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease
    Sui, Yutong
    Geng, Xue
    Wang, Ziwei
    Zhang, Jing
    Yang, Yanqun
    Meng, Ziyu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 157
  • [42] Uncovering ferroptosis in Parkinson's disease via bioinformatics and machine learning, and reversed deducing potential therapeutic natural products
    Wang, Peng
    Chen, Qi
    Tang, Zhuqian
    Wang, Liang
    Gong, Bizhen
    Li, Min
    Li, Shaodan
    Yang, Minghui
    FRONTIERS IN GENETICS, 2023, 14
  • [43] Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
    Alkhouri, Naim
    Carter-Kent, Christine
    Feldstein, Ariel E.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 5 (02) : 201 - 212
  • [44] Ferroptosis in cancer: Mechanisms, therapeutic strategies, and clinical implications
    Mamaghani, Mina Pourhabib
    Mousavikia, Seyedeh Nasibeh
    Azimian, Hosein
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 269 : 155907
  • [45] Therapeutic Targets and Natural Product Screening for Cognitive Impairments Associated with Ferroptosis in Wilson's Disease
    Wang, Xie
    Chen, Hong
    Zhang, Xiaoyan
    Shao, Nan
    Chang, Ze
    Xie, Daojun
    Zhang, Juan
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2024, 52 (08): : 2423 - 2452
  • [46] Exploring the therapeutic implications of inducing ferroptosis in oral carcinoma
    Reddy, Mamatha G. S.
    Negi, Sapna
    Tripathy, Snehasish
    Mehta, Vini
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2024, 125 (05)
  • [47] Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
    Li, Le
    Zhu, Zhijun
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [48] Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease
    Zhao, Shengnan
    Guo, Yan
    Yin, Xunzhe
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12):
  • [49] Therapeutic Insights on Ferroptosis in Parkinson's disease
    Thapa, Komal
    Khan, Heena
    Kanojia, Neha
    Singh, Thakur Gurjeet
    Kaur, Amarjot
    Kaur, Gagandeep
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 930
  • [50] Ferroptosis in liver disease: new insights into disease mechanisms
    Wu, Jing
    Wang, Yi
    Jiang, Rongtao
    Xue, Ran
    Yin, Xuehong
    Wu, Muchen
    Meng, Qinghua
    CELL DEATH DISCOVERY, 2021, 7 (01)